Market revenue in 2022 | USD 9.0 million |
Market revenue in 2030 | USD 23.5 million |
Growth rate | 12.7% (CAGR from 2022 to 2030) |
Largest segment | Stem cells |
Fastest growing segment | Other Products |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stem cells, Other Products |
Key market players worldwide | Boehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.
Stem cells was the largest segment with a revenue share of 52.22% in 2022. Horizon Databook has segmented the France veterinary regenerative medicine market based on stem cells, other products covering the revenue growth of each sub-segment from 2018 to 2030.
Several pharmaceutical and biotech companies in France were involved in developing and producing animal regenerative medicines. These companies collaborated with researchers, academia, veterinary clinics, and global players to bring new therapies.
Furthermore, some French companies that developed regenerative medicines for animals expanded their reach globally, contributing to the regional market growth. In February 2023, Vetbiobank, a pharmaceutical and biotech company headquartered in France, partnered strategically with Virbac, a prominent global player in the veterinary industry.
This collaboration aims to create innovative technology to address a novel indication in the field, presenting significant growth prospects for key industry players to expand their worldwide presence and strengthen their market position. They are working together to develop a cutting-edge therapy utilizing neonatal stem cells to treat a chronic inflammatory disease in animals.
Horizon Databook provides a detailed overview of country-level data and insights on the France veterinary regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into France veterinary regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account